August 28, 2020
MEDRx, a Tokyo-based developer of drugs based on a transdermal absorption system, and Nagoya-headquartered D. Western Therapeutics said on August 27 that they have filed for US approval of a tape formulation of lidocaine, which has been jointly developed by...read more